European Journal of Pediatrics

, Volume 167, Issue 7, pp 771–776

Infantile cardiomyopathy caused by the T14709C mutation in the mitochondrial tRNA glutamic acid gene

  • Johan L. K. Van Hove
  • Cynthia Freehauf
  • Shelley Miyamoto
  • Georgirene D. Vladutiu
  • Jacklyn Pancrudo
  • Eduardo Bonilla
  • Mark A. Lovell
  • Gary W. Mierau
  • Janet A. Thomas
  • Sara Shanske
Original Paper


A 6-week-old child presented with hypotonia, myopathy, and a rapidly worsening dilated cardiomyopathy with severe atrial and ventricular arrhythmias and pulmonary hypertension, which proved fatal at age 3 months. Biochemical analysis showed a combined deficiency of the enzymatic activities of complexes I and IV and molecular studies identified a T14709C mutation in the mitochondrial tRNA glutamic acid gene. A review of symptomatology in patients with this mutation shows that it mainly presents in childhood or young adults with mild myopathy and diabetes mellitus. Infants with a high, nearly homoplasmic mutant load can present with more severe symptoms including cardiomyopathy. Families with this mitochondrial DNA mutation should be aware that increased mutant load in a subsequent generation may result in severe and often fatal cardiac symptoms.


Mitochondrial respiratory chain tRNA glutamic acid Cardiomyopathy Arrhythmias Heteroplasmy 



mitochondrial DNA


transfer RNA


cytochrome c oxidase


adenosine triphosphate


adenosine diphosphate


restriction fragment length polymorphism


polymerase chain reaction


polyacrylamide gel electrophoresis


  1. 1.
    Antonicka H, Ogilvie I, Taivassalo T, Anitori RP, Halter RG, Vissing J, Kennaway NG, Shoubridge EA (2003) Identification and characterization of a common set of complex I assembly intermediates in mitochondria from patients with complex I deficiency. J Biol Chem 278:43081–43088PubMedCrossRefGoogle Scholar
  2. 2.
    Barclay AR, Shollier G, Christodoulou J, Shun A, Arbuckle S, Dorney S, Stormon MO (2005) Pulmonary hypertension: a new manifestation of mitochondrial disease. J Inher Metab Dis 28:1081–1089PubMedCrossRefGoogle Scholar
  3. 3.
    Choo-Kang ATW, Lynn S, Taylor GA, Daly ME, Sihota SS, Wardell TM, Chinnery PF, Turnbull DM, Walker M (2002) Defining the importance of mitochondrial gene defects in maternally inherited diabetes by sequencing the entire mitochondrial genome. Diabetes 51:2317–2320PubMedCrossRefGoogle Scholar
  4. 4.
    Damore ME, Speiser PW, Slonim AE, Newe MI, Shanske S, Xia W, Santorelli FM, DiMauro S (1999) Early onset diabetes mellitus associated with the mitochondrial DNA T14709C point mutation: patient report and literature review. J Pediatr Endocrin Metab 12:207–213Google Scholar
  5. 5.
    Hanna MG, Nelson I, Sweeney MG, Cooper JM, Watkins PJ, Morgan-Hughes JA, Harding AE (1995) Congenital encephalomyopathy and adult-onset myopathy and diabetes mellitus: different phenotypic associations of a new heteroplasmic mtDNA tRNA glutamic acid mutation. Am J Hum Genet 56:1026–1033PubMedGoogle Scholar
  6. 6.
    Hao H, Bonilla E, Manfredi G, DiMauro S, Moraes CT (1995) Segregation patterns of a novel mutation in the mitochondrial tRNA glutamic acid gene associated with myopathy and diabetes mellitus. Am J Hum Genet 56:1017–1025PubMedGoogle Scholar
  7. 7.
    Holmgren D, Wåhlander H, Eriksson BO, Oldfors A, Holme E, Tulinius M (2003) Cardiomyopathy in children with mitochondrial disease. Eur Heart J 24:280–288PubMedCrossRefGoogle Scholar
  8. 8.
    King T, Howard R (1967) Preparation of succinate dehydrogenase and reconstitution of succinate oxidase. In: Estabrook R, Pullman M (eds) Methods in enzymology: oxidation and phosphorylation, vol 10. Academic Press, New York, pp 322–328CrossRefGoogle Scholar
  9. 9.
    King T, Howard RL (1967) Preparation and properties of NADH dehydrogenase from cardiac muscle. In: Estabrook R, Pullman M (eds) Methods in enzymology: oxidation and phosphorylation, vol 10. Academic Press, New York, pp 275–294CrossRefGoogle Scholar
  10. 10.
    Mancuso M, Ferraris S, Nishigaki Y, Azan G, Mauro A, Sammarco P, Krishna S, Tay SKH, Bonilla E, Romansky SG, Hirano M, DiMauro S (2005) Congenital or late-onset myopathy in patients with the T14709C mtDNA mutation. J Neurol Sci 228:93–97PubMedCrossRefGoogle Scholar
  11. 11.
    McFarland R, Schaefer AM, Gardner JL, Lynn S, Hayes CM, Barron MJ, Walker M, Chinnery PF, Taylor RW, Turnbull DM (2004) Familial myopathy: new insights into the T14709C mitochondrial tRNA mutation. Ann Neurol 55:478–484PubMedCrossRefGoogle Scholar
  12. 12.
    Meulemans A, Seneca S, Smet J, De Paepe B, Lissens W, Van Coster R, Debeer A, De Meirleir L, Jaeken J (2007) A new family with the mitochondrial tRNAGLU gene mutation m.14709T>C presenting as hydrops fetalis. Eur J Pediatr Neurol 11:17–20CrossRefGoogle Scholar
  13. 13.
    Narbonne H, Paquis-Fluckinger V, Valero R, Heyries L, Pellisier JF, Vialettes B (2004) Gastrointestinal tract symptoms in maternally inherited diabetes and deafness (MIDD). Diabetes Metab 30:61–66PubMedCrossRefGoogle Scholar
  14. 14.
    Rigoli L, Prisco F, Caruso RA, Iafusco D, Ursomanno G, Zucarello D, Ingenito N, Rigoli M, Barberi I (2001) Association of the T14709C mutation of mitochondrial DNA with maternally inherited diabetes mellitus and/or deafness in an Italian family. Diabetic Med 18:334–336PubMedCrossRefGoogle Scholar
  15. 15.
    Schagger H, von Jagow G (1991) Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form. Anal Biochem 199:223–231PubMedCrossRefGoogle Scholar
  16. 16.
    Schon EA (2006) Appendix. In: DiMauro S, Hirano M, Schon EA (eds.) Mitochondrial medicine. Taylor & Francis, London, pp 329–335Google Scholar
  17. 17.
    Shanske S, Pancrudo J, Kaufmann P, Engelstad K, Jhung S, Lu J, Naini A, DiMauro S, De Vivo DC (2004) Varying loads of the mitochondrial DNA A3243G mutation in different tissues: implications for diagnosis. Am J Med Genet A 130:134–137PubMedCrossRefGoogle Scholar
  18. 18.
    Srere P (1969) Citrate synthase. In: Lowenstein J (ed) Methods in enzymology, vol 13. Academic Press, New York, pp 3–11Google Scholar
  19. 19.
    Vialettes BH, Paquis-Flucklinger V, Pellisier JF, Bendaham D, Narbonne H, Silverstre-Aillaud P, Montfort MF, Righini-Chossegros M, Pouget J, Cozzone PJ, Desnuelle C (1997) Phenotypic expression of diabetes secondary to a T14709C mutation of mitochondrial DNA: comparison with MIDD syndrome (A3243G mutation): a case report. Diabetes Care 20:1731–1737PubMedCrossRefGoogle Scholar
  20. 20.
    Wharton DC, Tzagoloff A (1967) Cytochrome c oxidase from beef heart mitochondria. In: Estabrook R, Pullman M (eds) Methods in enzymology, vol 10. Academic Press, New York, pp 245–250Google Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Johan L. K. Van Hove
    • 1
    • 5
  • Cynthia Freehauf
    • 1
  • Shelley Miyamoto
    • 1
  • Georgirene D. Vladutiu
    • 2
  • Jacklyn Pancrudo
    • 3
  • Eduardo Bonilla
    • 3
  • Mark A. Lovell
    • 4
  • Gary W. Mierau
    • 4
  • Janet A. Thomas
    • 1
  • Sara Shanske
    • 3
  1. 1.The Department of PediatricsThe University of Colorado at Denver Health Sciences Center and The Children’s HospitalDenverUSA
  2. 2.Department of PediatricsThe State University of New York at BuffaloBuffaloUSA
  3. 3.Department of NeurologyColumbia College of Physicians and SurgeonsNew YorkUSA
  4. 4.The Department of PathologyThe University of Colorado at Denver Health Sciences Center and The Children’s HospitalDenverUSA
  5. 5.Clinical Genetics and Metabolism, Department of PediatricsUniversity of Colorado Health Sciences Center at FitzsimmonsAuroraUSA

Personalised recommendations